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background:  Molecular diagnosis for the subjects with extremely low HDL cholesterol using candidate-gene approaches have required a 
huge effort for a long time. Whole exome sequencing (WES) technologies have already accelerated genetic studies of Mendelian disorders, 
yielding approximately ~30 % of success for diagnosing, and there is great interest in extending this approach to this rare phenotype.
Methods and Results:  WES was performed on 7 individuals including one individual exhibiting extremely low HDL cholesterol levels (2 
mg/dl), her parents, and 4 controls with different lipid phenotypes (high HDL cholesterol and high LDL cholesterol). Among 305,202 variants 
found in those individuals, we found 21,708 nonsense, missense, or splice site variants, of which 5,192 were rare (minor allele frequency 
≤0.01 or not reported) in 1000 Genome (Asian population). Filtering assuming recessive pattern of inheritance successfully narrowed down 
the candidate to the compound heterozygous mutations in ATP-binding cassette transporter 1 (ABCA1) gene (c.7173G>T or p.P2077H 
/ c.6223C>T or p.S2046N). She was genetically diagnosed as recessive form of familial hypoalphalipoproteinemia (FHA) with novel 
mutations.
conclusion:  WES identified recessive form of FHA with novel ABCA1 mutations for the first time. Such comprehensive approach is 
useful to determine true causative variants in recessive form of inherited diseases. Those results provide new insights into the novel 
pharmacological target for ABCA1.
